|
Home > Clinical Trials Search > Active Clinical Trials Search
Active Clinical Trials
Below is a listing of our current research activities. If you are interested in participating in a
clinical trial, please call the study contact or contact the Columbia St. Mary's Clinic Trials Office.
Category: Low Back Pain
Sub Category: Leg Pain, Spondylolisthesis, Lumbar Spinal Stenosis
Title: A Prospective, Multi-Center Clinical Study to Assess the Safety and Effectiveness of the Impliant TOPSTM System
Principal Investigator: Stephen Robbins, MD
Facility: Columbia St. Mary's Hospital Columbia
Contact: 414-961-2225
Category: Prostate Cancer
Sub Category: Radiation Therapy
Title: Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT vs.
AS and 3DCRT/IMRT Followed by Chemotherapy with Docetaxel and Prednisone for Localized, High-Risk Prostate Cancer (RTOG 0521).
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus
Contact: Debby Baumgarten, RN
- 414-291-1517
Category: Cardiovascular Disease
Sub Category: Heart Attack
Title: The IMMEDIATE (Immediate Metabolic Myocardial Enhancement During Initial Assessment and Treatment in Emergency Care) Trial is a NIH National Heart, Lung, Blood Institute sponsored study that is testing whether giving an Intravenous (IV) solution of readily available medications (Glucose, Insulin and potassium), referred to as “GIK” is helpful to patients at the first signs of a heart attack.
Principal Investigator: Thomas Aufderheide, MD
Facility: Columbia St. Mary's Hospitals Milwaukee and Ozaukee
Contact: Research Staff
- 414-805-9323
Category: Prostate Cancer
Sub Category: Radiation Therapy
Title: A Phase III Study Comparing Combined External Beam Radiation And Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone For Selected Patients With Intermediate Risk Prostatic Carcinoma (RTOG 0232)
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus
Contact: Debby Baumgarten, RN
- 414-291-1517
Category: Breast Implants (Silicone Gel)
Sub Category: Breast Reconstruction
Title: Mentor Memory Gel Implant Post Approval Study
Principal Investigator: Harvey Bock, MD, Kenneth Dembny, MD, Lawrence Sterkin, MD
Facility: Columbia St. Mary's Hospitals Milwaukee and Ozaukee
Contact: Angela
- 414-443-0033
Category: Peripheral Artery Disease
Sub Category: Critical Limb Ischemia and Severe Claudication
Title: Primary Stent Supported Angioplasty for Treatment of Below Knee Critical Limb Ischemia and Severe Life Style Limiting Claudication
Principal Investigator: Andrew Feiring, MD
Facility: Columbia St. Mary's Hospital Columbia
Contact: Mari Krahn, RN
- 414-961-3757
Category: Orthopedics
Sub Category: Knee Replacement
Title: Triathlon Cruciate Retaining (CR) Outcomes Study
Principal Investigator: Joseph Davies, MD
Facility: Columbia St. Mary's Hospital Ozaukee
Contact: Patrick Geiger
- 414-276-6000
Category: Low Back Pain
Sub Category: Degenerative Disc Disease
Title: A Prospective, Multicenter, Randomized, Study Comparing the use of
HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach
Principal Investigator: Max Lee, MD
Facility: Columbia St. Mary's – Columbia, Milwaukee and Ozaukee
Contact: Kelley Farnsworth, PA
- 414-438-6500
Category: Cardiovascular
Sub Category: Vascular
Title: Stenting and Angioplasty with Protection in Patients at High-Risk for
Endarterectomy - Sapphire WW
Principal Investigator: Andrew Feiring, MD
Facility: Columbia St. Mary's – Columbia and Ozaukee Campus
Contact: Mari Krahn, RN
- 414-961-3757
Category: Breast Cancer
Sub Category: Cancer
Title: CALGB 40101: Cyclophosphamide and Doxorubicin (CA 4 Vs 6 Cycles) Versus Paclitaxel (4 Vs 6 Cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2x2 Factorial Phase III Randomized Study
Principal Investigator: Carl Olson, MD
Facility: Prospect Medical Commons and Ozaukee Campus
Contact: Julie Hugg
- 414-319-3122
Category: Colon Cancer
Sub Category: Rectal Cancer
Title: CALGB/SWOG 80405: A Phase III Trial of Irinotecan/5-FU/Leucovorin or
Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's – Prospect Medical Commons and Ozaukee
Contact: Julie Hugg
- 414-319-3122
Category: Breast Cancer
Sub Category: Cancer
Title: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial). Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment.
Principal Investigator: Carl Olson, MD
Facility: Prospect Medical Commons and Ozaukee Campus
Contact: Julie Hugg
- 414-319-3122
Category: Intimate Partner Violence
Sub Category: Intimate Partner Violence
Title: Health Care Can Change from Within
Principal Investigator: L. Kevin Hamberger, Ph.D/ Bruce Ambuel, Ph.D
Facility: Columbia St. Mary's Family Health Center
Contact: Amy Kistner, MS, LPC
- 262-928-6953
Category: Cardiovascular
Sub Category: Cardiac Arrest
Title: Prehospital Resuscitation using an Impedance Valve and Early versus Delayed analysis (ROC PRIMED) Trial
Principal Investigator: Tom Aufderheide, MD
Facility: Columbia St. Mary's – Columbia, Milwaukee, Ozaukee Campus
Contact: David Kitscha, MCW
- 414-805-2572
Category: Endometrial Cancer
Sub Category: Cancer
Title: A Randomized Phase III Trial Of Doxorubicin/Cisplatin/Paclitaxel/G-CSF Versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer (GOG 0209)
Principal Investigator: David Boruta, MD
Facility: Columbia St. Mary's Water Tower Medical Commons, Prospect Medical Commons, Ozaukee Campus
Contact: Julie Hugg
- 414-319-3122
Category: Head and Neck Cancer
Sub Category: Cancer
Title: RTOG 0522: A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus
Contact: Debby Baumgarten, RN
- 414-291-1517
Category: Prostate Cancer
Sub Category: Cancer
Title: A Phase III Randomized Study of Hypofractionated 3d-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate Cancer (RTOG 0415)
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus
Contact: Debby Baumgarten, RN
- 414-291-1517
Category: Prostate Cancer
Sub Category: Cancer
Title: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (RTOG 0534)
Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus
Contact: Debby Baumgarten, RN
- 414-291-1517
Category: Lung Cancer (Non-Small Cell Lung Cancer (NSCLC)
Sub Category: Cancer
Title: A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)(ECOG 1505)
Principal Investigator: Charles Tiber, MD
Facility: Columbia St. Mary's Prospect Medical Commons, Water Tower Medical Commons and Ozaukee Campus
Contact: Julie Hugg
- 414-319-3122
Category: Cardiovascular
Sub Category: Acute Coronary Syndrome
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care In Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)
Principal Investigator: Andrew Feiring, MD and Robert Roth, MD
Facility: Columbia St. Mary's - Columbia, Milwaukee, Ozaukee Campus
Contact: Mari Krahn, RN
- 414-961-3757
Category: Endometrial Hyperplasia
Sub Category: Endometrial Intraepithelial Neoplasia
Title: A Randomized, Controlled Phase II Evaluation of Megestrol (MEGACE) in Different Dose and Sequence in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) from a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN (GOG 0224)
Principal Investigator: Charles Tiber, MD
Facility: Columbia St. Mary's – Water Tower Medical Commons, Ozaukee Campus
Contact: Julie Hugg
- 414-291-1516
|
